An objective of this research is to verify the mechanism of anticoagulant activity of surface-immobilized heparin in the presence of plasma proteins. The competition and binding interaction between immobilized heparin and antithrombin I11 (ATIII)/thrombin have been described in vituo. However, the s
Control of contact activation on end-point immobilized heparin: The role of antithrombin and the specific antithrombin-binding sequence
β Scribed by Sanchez, J. ;Elgue, G. ;Riesenfeld, J. ;Olsson, P.
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 776 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0021-9304
No coin nor oath required. For personal study only.
β¦ Synopsis
The uptake and activation of FXII from blood plasma was studied in small-diameter polyethylene tubing, surfacemodified by end-point immobilization of heparin. Two preparations of heparin were used to modify the contactactivating properties of the plastic tubing: unfractionated, functionally active heparin and low-affinity heparin, lacking the specific antithrombin-binding sequence and virtually devoid of anticoagulant activity. The uptakes of FXII on the two heparin surfaces were similar. No activated FXII could be demonstrated on the unfractionated heparin surface, whereas on the low-affinity heparin surface nearly all FXII underwent spontaneous activation. The suppression of FXII activation on the unfractionated heparin surface was investigated by using plasma depleted of antithrombin, complement C1 esterase inhibitor, or both. The removal of antithrombin resulted in extensive activation of FXII, whereas the depletion of C1 esterase inhibitor had only a minor effect. Experiments with recalcified plasma showed rapid clot formation during exposure to the low-affinity heparin surface. After depletion of antithrombin, but not complement C1 esterase inhibitor, the recalcified plasma clotted in contact with the unfractionated heparin surface as well. We conclude that antithrombin and the antithrombin-binding sequence in the surface-immobilized heparin are essential for the prevention of surface activation of FXII and triggering of the intrinsic coagulation system.
π SIMILAR VOLUMES
## Abstract The interactions of antithrombin (AT) and the contact phase clotting factors with two commercially available heparinized surfaces are reported. The Carmeda (CBAS) and Corline surfaces along with controls (a sulfonated polyethylene surface and a CBAS analog in which the heparin used was
End-point immobilization of heparin to artificial activity in contact with plasma, either on the exposed surfaces materials gives rise to a surface that prevents triggering of or in the plasma phases. Below this level, the degree of the plasma contact activation system and, presumably as a activatio